← Open Payments lookup

ROSHUNYA CLARK: Open Payments

NPI 1497292049 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$775 in 29 payments from 10 companies in 2025. Trend: 2023 $1,808 · 2024 $929 · 2025 $775

Food & beverage: $775
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$186
Indivior Inc.6$172
ABBVIE INC.8$169
Teva Pharmaceuticals USA, Inc.3$68
Otsuka America Pharmaceutical, Inc.2$41
Alkermes, Inc.2$38
E.R. Squibb & Sons, L.L.C.2$32
Janssen Pharmaceuticals, Inc1$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Axsome Therapeutics, Inc.1$16

Products named: INGREZZA, SUBLOCADE, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, ARISTADA, COBENFY, INVEGA SUSTENNA.

Industry payments across FL — which companies pay providers there.